MORAN KEVIN PATRICK 1806596 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-01 | 2023-07-28 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | holding | 635.0 | 0 | 0.11 | 0.0 | By Wife | Common Stock | VANDA PHARMACEUTICALS INC. | NA | 57.51 (VNDA) | ||
| 2023-08-01 | 2023-07-28 | 2023-07-28 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | dsp | 2212.0 | 1.8 | 0.38 | 6.3 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code S | 120714.0
|
57.51 (VNDA) |
| 2023-06-20 | 2023-06-15 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | holding | 635.0 | 0 | 0.11 | 0.0 | By Wife | Common Stock | VANDA PHARMACEUTICALS INC. | NA | 57.44 (VNDA) | ||
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | dsp | 16000.0 | 11.52 | 2.79 | 6.29 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code S | 122926.0 | 57.44 (VNDA) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | acq | 125000.0 | 50.87 | 21.72 | 0.0 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code A | 245714.0 | 57.54 (VNDA) |
| 2024-02-21 | 2024-02-16 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | holding | 635.0 | 0 | 0.11 | 0.0 | By Wife | Common Stock | VANDA PHARMACEUTICALS INC. | NA | 57.54 (VNDA) | ||
| 2024-03-06 | 2024-03-04 | 2024-03-04 to 2024-03-05 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | dsp | 14700.0 | 5.98 | 2.55 | 4.31 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code S | 231014.0
|
57.54 (VNDA) |
| 2024-03-06 | 2024-03-04 | 4 | Moran Kevin Patrick | SVP, CFO & TREASURER | holding | 635.0 | 0 | 0.11 | 0.0 | By Wife | Common Stock | VANDA PHARMACEUTICALS INC. | NA | 57.54 (VNDA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)